Rational Advisors’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-11
Closed -$8K 249
2020
Q3
$8K Sell
11
-2
-15% -$1.56K ﹤0.01% 301
2020
Q2
$10K Buy
+13
New +$9.8K 0.01% 357
2020
Q1
Sell
-55
Closed -$62K 206
2019
Q4
$62K Buy
55
+25
+83% +$27.2K 0.03% 335
2019
Q3
$36K Buy
30
+25
+500% +$38.2K 0.01% 399
2019
Q2
$8K Buy
5
+4
+400% +$6.92K ﹤0.01% 494
2019
Q1
$3K Sell
1
-18
-95% -$31.7K ﹤0.01% 479
2018
Q4
$24K Buy
19
+14
+280% +$21.5K 0.01% 339
2018
Q3
$9K Buy
5
+4
+400% +$8.26K ﹤0.01% 400
2018
Q2
$1K Sell
1
-5
-83% -$11.4K ﹤0.01% 451
2018
Q1
$14K Buy
+6
New +$15.3K 0.01% 351

Other funds holding BLUE

Rational Advisors's BLUE Position: Q4 2020 in Review

Rational Advisors sold out of bluebird bio (BLUE) in Q4 2020, closing a stake of 11 shares — an estimated $8K sold.

Rational Advisors first reported a position in BLUE in Q1 2018 and held it in 10 quarters. The position peaked at $62K in Q4 2019. 262 funds tracked by Wall St. Rank hold BLUE as of Q4 2020.

  • Rational Advisors reported no remaining bluebird bio position as of Q4 2020 after selling out during the quarter.
  • Rational Advisors sold 11 bluebird bio shares in Q4 2020, an estimated $8K.
  • Rational Advisors first reported a position in bluebird bio in Q1 2018 and held it in 10 quarters.
  • Rational Advisors's bluebird bio position peaked at $62K in Q4 2019.
  • 262 funds tracked by Wall St. Rank held bluebird bio as of Q4 2020.

Based on Rational Advisors's 13F filing for Q4 2020, filed 5 Feb 2021.